Urology · Alpena, MI
NPI
1225092554
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1065 US 23 North
Alpena, MI, 49707
Phone (989) 354-0607
Groups this clinician bills Medicare through
Medicare paid, 2024
$230K
8,755 services
Medicare patients, 2024
777
Average age 76
Drug cost, 2024
$617K
4,433 prescriptions
Company payments, 2025
$222
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bradley A Boehm was code 81000 (clinical chemistry), 1,049 times for 638 patients. In total Bradley A Boehm billed 8,755 services in 64 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81000 Clinical Chemistry | Office | 1,049 | 638 | $3.92 | $4,117 |
| 99213 Office E&M - Established | Office | 670 | 504 | $60.64 | $41K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 366 | 43 | $139.81 | $51K |
| 99214 Office E&M - Established | Office | 353 | 269 | $88.93 | $31K |
| 36415 Venipuncture Blood Collection | Office | 304 | 210 | $8.62 | $2,621 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 184 | 46 | $0.36 | $66.89 |
| 51798 Ultrasound - Nonspecific | Office | 112 | 97 | $7.26 | $813 |
| 96402 Chemotherapy Administration | Office | 108 | 43 | $25.10 | $2,710 |
| 52000 Cystourethroscopy | Office | 90 | 74 | $177.54 | $16K |
| 99204 Office E&M - New | Office | 88 | 88 | $113.86 | $10K |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 79 | 46 | $2.03 | $161 |
| 99203 Office E&M - New | Office | 77 | 77 | $73.47 | $5,657 |
| 76942 Ultrasound - Nonspecific | Office | 56 | 51 | $45.95 | $2,573 |
| A4648 Tissue marker, implantable, any type, each | Office | 54 | 18 | $63.79 | $3,445 |
| 55700 Other Organ Systems | Office | 46 | 46 | $183.28 | $8,431 |
By year: 2022 $283K for 29,815 services; 2023 $252K for 21,025 services; 2024 $230K for 8,755 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 1,049 | 638 | $3.92 | $4,117 |
| 36415 Venipuncture Blood Collection | 304 | 210 | $8.62 | $2,621 |
Medicare prescription drug claims, 2024
In 2024, the drug Bradley A Boehm prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,089 prescriptions and refills. In total Bradley A Boehm wrote 4,433 Medicare prescriptions that cost $617K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,089 | 2,795 | 333 | $27K |
| Finasteride Generic | 685 | 1,794 | 218 | $13K |
| Myrbetriq Mirabegron | 315 | 565 | 82 | $240K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 214 | 412 | 52 | $6,561 |
| Gemtesa Vibegron | 205 | 404 | 62 | $184K |
| Cephalexin Generic | 187 | 314 | 106 | $1,882 |
| Ciprofloxacin Hcl Generic | 187 | 209 | 165 | $731 |
| Trimethoprim Generic | 167 | 407 | 48 | $14K |
| Solifenacin Succinate Generic | 166 | 367 | 54 | $8,120 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 150 | 150 | 125 | $154 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 121 | 253 | 36 | $11K |
| Diazepam Generic | 117 | 117 | 100 | $53.7 |
| Levofloxacin Generic | 62 | 62 | 50 | $220 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 58 | 112 | 12 | $6,142 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 58 | 112 | 33 | $1,883 |
Brand drugs: 717 claims; generic drugs: 3,716 claims; opioid claims: 164.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bradley A Boehm $222 ($222 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $157.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.